Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Unusual Bioactive Compounds with Antioxidant Properties in Adjuvant Therapy Supporting Cognition Impairment in Age-Related Neurodegenerative Disorders.

Tytuł:
Unusual Bioactive Compounds with Antioxidant Properties in Adjuvant Therapy Supporting Cognition Impairment in Age-Related Neurodegenerative Disorders.
Autorzy:
Cichon N; Biohazard Prevention Centre, Faculty of Biology and Environmental Protection, University of Lodz, Pomorska 141/143, 90-236 Lodz, Poland.
Dziedzic A; Department of General Biochemistry, Faculty of Biology and Environmental Protection, University of Lodz, Pomorska 141/143, 90-236 Lodz, Poland.
Gorniak L; Biohazard Prevention Centre, Faculty of Biology and Environmental Protection, University of Lodz, Pomorska 141/143, 90-236 Lodz, Poland.
Miller E; Department of Neurological Rehabilitation, Medical University of Lodz, Milionowa 14, 93-113 Lodz, Poland.
Bijak M; Biohazard Prevention Centre, Faculty of Biology and Environmental Protection, University of Lodz, Pomorska 141/143, 90-236 Lodz, Poland.
Starosta M; Department of Neurological Rehabilitation, Medical University of Lodz, Milionowa 14, 93-113 Lodz, Poland.
Saluk-Bijak J; Department of General Biochemistry, Faculty of Biology and Environmental Protection, University of Lodz, Pomorska 141/143, 90-236 Lodz, Poland.
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2021 Oct 02; Vol. 22 (19). Date of Electronic Publication: 2021 Oct 02.
Typ publikacji:
Journal Article; Review
Język:
English
Imprint Name(s):
Original Publication: Basel, Switzerland : MDPI, [2000-
MeSH Terms:
Aging*
Antioxidants/*therapeutic use
Biological Products/*therapeutic use
Cognition Disorders/*drug therapy
Cognition Disorders/*etiology
Neurodegenerative Diseases/*complications
Animals ; Antioxidants/pharmacology ; Biological Products/pharmacology ; Clinical Trials as Topic ; Cognition/drug effects ; Cognition Disorders/diagnosis ; Cognitive Dysfunction/diagnosis ; Cognitive Dysfunction/drug therapy ; Cognitive Dysfunction/etiology ; Dietary Supplements ; Drug Evaluation, Preclinical ; Humans ; Neurodegenerative Diseases/drug therapy ; Neurodegenerative Diseases/etiology ; Treatment Outcome
References:
Neurology. 2019 Mar 19;92(12):e1322-e1330. (PMID: 30787164)
Nutr Res. 2019 Jun;66:1-12. (PMID: 31022563)
J Neurotrauma. 2012 Nov 1;29(16):2576-86. (PMID: 22853439)
Dis Model Mech. 2017 May 1;10(5):499-502. (PMID: 28468935)
Pharm Res. 2011 Dec;28(12):3171-9. (PMID: 21681606)
Front Neurol. 2020 Feb 14;11:88. (PMID: 32117038)
Cold Spring Harb Perspect Biol. 2017 Jul 5;9(7):. (PMID: 28062563)
Neurobiol Aging. 2013 Jun;34(6):1555-63. (PMID: 23402899)
Acta Pharmacol Sin. 2009 Dec;30(12):1648-58. (PMID: 19960010)
Adv Nutr. 2017 Jul 14;8(4):571-586. (PMID: 28710144)
J Neurosci. 2005 Sep 21;25(38):8807-14. (PMID: 16177050)
CNS Neurol Disord Drug Targets. 2016;15(5):602-13. (PMID: 27071792)
Lancet Neurol. 2016 Jul;15(8):801-810. (PMID: 27302362)
Neuroreport. 2016 Jun 15;27(9):671-6. (PMID: 27145228)
Mayo Clin Proc. 2014 Oct;89(10):1452-9. (PMID: 25282431)
Neurochem Res. 2009 Apr;34(4):670-8. (PMID: 18683046)
Br J Pharmacol. 2013 Jan;168(2):421-31. (PMID: 22891631)
Am J Alzheimers Dis Other Demen. 2009 Feb-Mar;24(1):27-33. (PMID: 19056706)
Adv Nutr. 2021 Oct 1;12(5):1821-1837. (PMID: 34167148)
Nutrients. 2021 Jan 29;13(2):. (PMID: 33572715)
Psychogeriatrics. 2021 Jan;21(1):80-88. (PMID: 33207393)
CNS Neurosci Ther. 2019 May;25(5):575-590. (PMID: 30676698)
Diabetes. 2018 Aug;67(8):1576-1588. (PMID: 29784660)
Arch Biochem Biophys. 2004 Apr 15;424(2):181-8. (PMID: 15047190)
Lipids Health Dis. 2018 Jun 23;17(1):146. (PMID: 29935544)
Gerontology. 1987;33(3-4):159-67. (PMID: 2888709)
Arch Biochem Biophys. 2009 Dec;492(1-2):1-9. (PMID: 19822127)
Biochem Biophys Rep. 2017 Jan 05;9:180-186. (PMID: 28956003)
Mol Neuropsychiatry. 2018 May;3(4):214-222. (PMID: 29888232)
J Am Med Dir Assoc. 2020 Oct;21(10):1402-1409. (PMID: 32981667)
Curr Opin Neurobiol. 2006 Dec;16(6):710-5. (PMID: 17011181)
Clin Sci (Lond). 2002 May;102(5):595-600. (PMID: 11980580)
Am J Alzheimers Dis Other Demen. 2015 Mar;30(2):183-91. (PMID: 25024455)
J Neurol Sci. 2015 Nov 15;358(1-2):46-52. (PMID: 26298797)
J Pharm Pharmacol. 2011 Mar;63(3):342-51. (PMID: 21749381)
J Alzheimers Dis. 2020;77(4):1373-1382. (PMID: 32925057)
Chemosphere. 2016 Feb;144:2004-12. (PMID: 26551198)
BMC Geriatr. 2019 Oct 16;19(1):272. (PMID: 31619178)
Br J Nutr. 2020 Jan 28;123(2):182-189. (PMID: 31870463)
Neural Regen Res. 2013 Apr 25;8(12):1081-90. (PMID: 25206402)
Clin Pharmacol Ther. 2019 Oct;106(4):884-890. (PMID: 31206613)
Free Radic Biol Med. 2011 Oct 1;51(7):1329-36. (PMID: 21741473)
Cell Death Dis. 2019 Feb 12;10(2):128. (PMID: 30755589)
Muscle Nerve. 2021 Apr;63(4):572-576. (PMID: 33428242)
J Alzheimers Dis. 2014;39(2):271-82. (PMID: 24164735)
Clin Drug Investig. 2019 Jul;39(7):607-624. (PMID: 31054087)
Exp Neurobiol. 2015 Dec;24(4):325-40. (PMID: 26713080)
Molecules. 2018 Dec 13;23(12):. (PMID: 30551603)
J Psychiatr Res. 2020 Nov;130:424-432. (PMID: 32891918)
Oxid Med Cell Longev. 2020 Sep 22;2020:4751349. (PMID: 33029280)
Neuropsychol Rev. 2018 Dec;28(4):509-533. (PMID: 30343458)
J Alzheimers Dis. 2020;78(1):127-137. (PMID: 32925042)
Nature. 2014 Nov 13;515(7526):299-300. (PMID: 25396246)
J Pathol. 2010 Dec;222(4):329-34. (PMID: 20922714)
Exp Ther Med. 2014 Oct;8(4):1285-1290. (PMID: 25187841)
Ageing Res Rev. 2017 May;35:222-240. (PMID: 27713095)
Nutrients. 2017 Apr 07;9(4):. (PMID: 28387721)
Brain Sci. 2021 Aug 25;11(9):. (PMID: 34573143)
Evid Based Complement Alternat Med. 2012;2012:823206. (PMID: 21792372)
Pharm Biol. 2018 Dec;56(1):465-484. (PMID: 31070530)
Alzheimers Dement. 2015 Sep;11(9):1007-14. (PMID: 25681666)
Poult Sci. 2021 Aug 20;100(11):101437. (PMID: 34547622)
J Pharm Pharmacol. 2018 Jan;70(1):70-80. (PMID: 28994117)
Oxid Med Cell Longev. 2017;2017:7984327. (PMID: 28265338)
J Neurochem. 2001 Sep;78(5):1073-82. (PMID: 11553681)
Clin Drug Investig. 2016 Sep;36(9):713-724. (PMID: 27352310)
J Alzheimers Dis. 2015;48(3):591-5. (PMID: 26402075)
Mol Nutr Food Res. 2017 Dec;61(12):. (PMID: 28891114)
Acta Pharmacol Sin. 2019 Nov;40(11):1490-1500. (PMID: 31092885)
J Nutr. 2009 Oct;139(10):1987-93. (PMID: 19656855)
J Agric Food Chem. 2004 Jun 30;52(13):4128-32. (PMID: 15212458)
Syst Biol Reprod Med. 2008 Jul-Aug;54(4-5):169-76. (PMID: 18942024)
Genes Nutr. 2008 Dec;3(3-4):115-26. (PMID: 18937002)
Neuroscience. 2019 Dec 15;423:29-37. (PMID: 31678348)
J Pineal Res. 2012 Mar;52(2):167-202. (PMID: 22107053)
Front Aging Neurosci. 2018 Dec 06;10:399. (PMID: 30574085)
J Integr Neurosci. 2020 Dec 30;19(4):679-685. (PMID: 33378842)
Neurosci Lett. 2009 Aug 28;460(2):103-7. (PMID: 19515491)
Appetite. 2012 Apr;58(2):767-70. (PMID: 22127270)
Antioxidants (Basel). 2020 Oct 23;9(11):. (PMID: 33114058)
J Asian Nat Prod Res. 2012;14(1):14-21. (PMID: 22263589)
Ther Adv Psychopharmacol. 2012 Aug;2(4):131-8. (PMID: 23983966)
Neural Regen Res. 2012 Feb 15;7(5):376-85. (PMID: 25774178)
Brain Res Bull. 2013 Jan;90:1-9. (PMID: 23041106)
Metab Brain Dis. 2015 Apr;30(2):537-44. (PMID: 25108596)
Oxid Med Cell Longev. 2018 May 2;2018:7074209. (PMID: 29854089)
Cell Metab. 2019 Mar 5;29(3):592-610. (PMID: 30840912)
Exp Neurol. 2013 Dec;250:239-49. (PMID: 24120440)
BMC Nutr. 2021 Jun 9;7(1):21. (PMID: 34103072)
EFSA J. 2018 Apr 18;16(4):e05239. (PMID: 32625874)
Brain Res. 2005 Mar 10;1037(1-2):209-13. (PMID: 15777772)
Antioxid Redox Signal. 2013 May 10;18(14):1818-92. (PMID: 22794138)
J Nutr. 2006 Apr;136(4):1043-7. (PMID: 16549472)
Nutrients. 2020 Feb 14;12(2):. (PMID: 32075202)
J Nat Med. 2015 Jul;69(3):358-65. (PMID: 25808015)
J Nutr Health Aging. 2009 Mar;13(3):189-97. (PMID: 19262950)
J Alzheimers Dis. 2018;62(4):1803-1813. (PMID: 29614663)
Nutrients. 2021 Jan 25;13(2):. (PMID: 33503851)
J Nutr Biochem. 2015 Mar;26(3):201-10. (PMID: 25468612)
J Neurochem. 2003 Jun;85(5):1101-8. (PMID: 12753069)
Front Pharmacol. 2021 Mar 10;12:643254. (PMID: 33776778)
Ann Transl Med. 2020 Jun;8(11):719. (PMID: 32617339)
Ann Transl Med. 2015 Jun;3(10):136. (PMID: 26207229)
Nutrients. 2020 Feb 11;12(2):. (PMID: 32053923)
Front Public Health. 2016 May 25;4:94. (PMID: 27252937)
Aust N Z J Psychiatry. 2020 May;54(5):453-466. (PMID: 31826654)
Perm J. 2005 Summer;9(3):38-41. (PMID: 22811627)
Acta Neuropathol. 2015 Feb;129(2):183-206. (PMID: 25604547)
Neurobiol Aging. 2014 Jun;35(6):1275-85. (PMID: 24468471)
J Ethnopharmacol. 2016 Feb 3;178:115-24. (PMID: 26657578)
Front Neurosci. 2016 Aug 23;10:386. (PMID: 27601977)
J Clin Psychopharmacol. 2010 Oct;30(5):573-8. (PMID: 20814335)
Int J Geriatr Psychiatry. 2017 Jan;32(1):50-57. (PMID: 27645169)
J Neuroinflammation. 2019 Jan 24;16(1):15. (PMID: 30678702)
J Alzheimers Dis. 2018;63(2):551-560. (PMID: 29630549)
Expert Opin Drug Saf. 2009 Jul;8(4):397-409. (PMID: 19538101)
Biochem Biophys Res Commun. 2017 Oct 21;492(3):493-499. (PMID: 28830814)
Chem Res Toxicol. 2000 Mar;13(3):177-84. (PMID: 10725114)
Eur J Clin Pharmacol. 1988;34(1):77-82. (PMID: 3360052)
Neurochirurgie. 2015 Apr-Jun;61(2-3):77-84. (PMID: 25908646)
J Nat Med. 2014 Jan;68(1):132-43. (PMID: 23749289)
J Am Heart Assoc. 2021 Jul 6;10(13):e019158. (PMID: 34189926)
Curr Neuropharmacol. 2009 Mar;7(1):65-74. (PMID: 19721819)
J Alzheimers Dis. 2015;45(2):395-405. (PMID: 25589719)
Cancer Res. 2001 Nov 1;61(21):7868-74. (PMID: 11691805)
Lancet Neurol. 2019 Aug;18(8):724-735. (PMID: 31278067)
Complement Ther Med. 2020 May;50:102366. (PMID: 32444045)
J Neuroimmunol. 2018 Jan 15;314:42-49. (PMID: 29150085)
Clin Pharmacokinet. 1991 Feb;20(2):123-34. (PMID: 2029805)
Neuropsychopharmacology. 2011 Oct;36(11):2233-43. (PMID: 21716263)
Lipids Health Dis. 2019 Nov 16;18(1):200. (PMID: 31733650)
Aging Dis. 2017 Dec 1;8(6):850-867. (PMID: 29344420)
J Neurochem. 2003 Mar;84(5):1173-83. (PMID: 12603840)
Mol Med Rep. 2015 Oct;12(4):6377-83. (PMID: 26300488)
Front Psychiatry. 2021 Jun 10;12:688890. (PMID: 34177671)
Brain Sci. 2018 Oct 11;8(10):. (PMID: 30314380)
Biofactors. 2000;13(1-4):205-9. (PMID: 11237183)
Mult Scler. 2015 Apr;21(5):580-9. (PMID: 25432947)
Am J Cardiol. 2008 May 22;101(10A):14D-19D. (PMID: 18474268)
J Nutr Health Aging. 2018;22(2):222-229. (PMID: 29380849)
Biochem Soc Trans. 2007 Nov;35(Pt 5):1119-21. (PMID: 17956292)
Neurochem Res. 2014 Aug;39(8):1533-43. (PMID: 24893798)
Molecules. 2019 Oct 06;24(19):. (PMID: 31590459)
Clin Drug Investig. 2016 Mar;36(3):169-75. (PMID: 26692007)
Genes (Basel). 2021 Jun 13;12(6):. (PMID: 34199279)
Front Endocrinol (Lausanne). 2019 Jul 16;10:480. (PMID: 31379746)
Neurosci Lett. 2004 Jan 30;355(3):231-5. (PMID: 14732473)
Mol Brain. 2015 Nov 24;8(1):78. (PMID: 26603284)
Curr Atheroscler Rep. 2001 Sep;3(5):392-8. (PMID: 11487450)
Int J Environ Res Public Health. 2016 Feb 29;13(3):. (PMID: 26938543)
Molecules. 2014 Nov 26;19(12):19610-32. (PMID: 25432012)
Neurol Sci. 2016 Jan;37(1):57-65. (PMID: 26255301)
Eur J Clin Nutr. 2021 Jul 6;:. (PMID: 34230628)
Am J Clin Nutr. 2021 Oct 4;114(4):1418-1427. (PMID: 34159358)
Br J Clin Pharmacol. 2016 Mar;81(3):471-81. (PMID: 26387650)
Br J Pharmacol. 2011 Oct;164(4):1357-91. (PMID: 21486284)
Alzheimers Dement. 2010 Jan;6(1):1-10.e1. (PMID: 20129316)
PLoS One. 2020 Apr 17;15(4):e0231379. (PMID: 32302347)
Stroke. 2021 Aug 10;:STROKEAHA120033214. (PMID: 34372670)
Molecules. 2019 Mar 21;24(6):. (PMID: 30901869)
Evid Based Complement Alternat Med. 2021 Feb 24;2021:6664217. (PMID: 33680059)
Ann Neurol. 2004 Oct;56(4):532-9. (PMID: 15389895)
Hum Psychopharmacol. 2012 Mar;27(2):177-86. (PMID: 22389082)
Biomed Pharmacother. 2017 Sep;93:543-553. (PMID: 28686968)
Atherosclerosis. 2011 Sep;218(1):44-52. (PMID: 21601209)
J Ethnopharmacol. 2014 Oct 28;156:210-5. (PMID: 25219601)
J Prev Alzheimers Dis. 2017;4(3):201-206. (PMID: 29182711)
Inflamm Res. 2007 May;56(5):210-5. (PMID: 17588137)
Neurosci Lett. 2013 Jun 24;546:57-62. (PMID: 23669639)
Front Neurol. 2018 Jan 15;8:744. (PMID: 29387038)
Alzheimers Dement. 2015 Sep;11(9):1015-22. (PMID: 26086182)
Nat Rev Neurosci. 2008 Jul;9(7):568-78. (PMID: 18568016)
Int J Nanomedicine. 2017 Sep 22;12:7007-7013. (PMID: 29026297)
Acta Biomed. 2018 Jun 07;89(2):276-290. (PMID: 29957766)
Ann Clin Transl Neurol. 2021 Apr;8(4):811-824. (PMID: 33675156)
ASN Neuro. 2020 Jan-Dec;12:1759091420981204. (PMID: 33342257)
J Nutr. 2007 May;137(5):1208-15. (PMID: 17449583)
J Ethnopharmacol. 2006 Jan 3;103(1):120-5. (PMID: 16159703)
J Alzheimers Dis. 2016;51(4):991-5. (PMID: 26967219)
IBRO Rep. 2020 Jun 01;9:37-45. (PMID: 33336102)
Alzheimers Dement (N Y). 2021 Mar 31;7(1):e12155. (PMID: 33816762)
Contributed Indexing:
Keywords: N-acetylcysteine; age-related neurodegenerative disease; antioxidants; cognition impairment; dementia; diet patterns; flavonoids; melatonin; propolis; sulforaphane
Substance Nomenclature:
0 (Antioxidants)
0 (Biological Products)
Entry Date(s):
Date Created: 20211013 Date Completed: 20211028 Latest Revision: 20211028
Update Code:
20240105
PubMed Central ID:
PMC8509433
DOI:
10.3390/ijms221910707
PMID:
34639048
Czasopismo naukowe
Cognitive function decline is strictly related to age, resulting in the loss of the ability to perform daily behaviors and is a fundamental clinical neurodegeneration symptom. It has been proven that an adequate diet, comprehensive nutrition, and a healthy lifestyle may significantly inhibit neurodegenerative processes, improving cognitive functions. Therefore, intensive research has been conducted on cognitive-enhancing treatment for many years, especially with substances of natural origin. There are several intervention programs aimed at improving cognitive functions in elderly adults. Cognitive functions depend on body weight, food consumed daily, the quality of the intestinal microflora, and the supplements used. The effectiveness in the prevention of dementia is particularly high before the onset of the first symptoms. The impact of diet and nutrition on age-associated cognitive decline is becoming a growing field as a vital factor that may be easily modified, and the effects may be observed on an ongoing basis. The paper presents a review of the latest preclinical and clinical studies on the influence of natural antioxidants on cognitive functions, with particular emphasis on neurodegenerative diseases. Nevertheless, despite the promising research results in animal models, the clinical application of natural compounds will only be possible after solving a few challenges.
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies